Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Leclercq

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Archives of Cardiovascular Diseases|April 16, 2016
One-year incidence and clinical impact of bleeding events in patients treated with prasugrel or clopidogrel after ST-segment elevation myocardial infarctionBenoit Lattuca, Pascale Fabbro-Peray, Florence Leclercq, et al.
Heart (British Cardiac Society)|March 15, 2018
Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarctionLamiae Grimaldi-Bensouda, Nicolas Danchin, Jean Dallongeville, et al.
International Journal of Cardiology|April 4, 2015
Impact of prolonged dual antiplatelet therapy after acute myocardial infarction on 5-year mortality in the FAST-MI 2005 registryFrancois Schiele, Etienne Puymirat, Laurent Bonello, et al.
International Journal of Clinical Practice|May 28, 2020
Collaboration between cardiologist and clinical pharmacist on prescription quality: What is the potential clinical impact for cardiology patients?Yohan Audurier, Nicolas Chapet, Pierre Renaudin, et al.
Archives of Cardiovascular Diseases|February 7, 2026
Tafamidis treatment in transthyretin cardiac amyloidosis: A retrospective cohort analysis of outcomes and associated factorsJohanna Krief, Sylvain Aguilhon, Quentin Delbaere, et al.
Archives of Cardiovascular Diseases|June 30, 2023
Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI programOrianne Weizman, Victoria Tea, Eloi Marijon, et al.
Clinical Chemistry and Laboratory Medicine|November 11, 2014
Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarctionKamila Solecki, Anne Marie Dupuy, Nils Kuster, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 6, 2025
A Streamline Strategy for Indication and Length of Telemetry Monitoring After TAVRAntonin Fournier, Pierre Robert, Benoit Lattuca, et al.
International Journal of Cardiology|February 7, 2018
Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA StudyJean-Philippe Collet, Guillaume Cayla, Pierre-Vladimir Ennezat, et al.
Journal of Clinical Medicine|April 12, 2022
Impact of Daily Bedside Echocardiographic Assessment on Readmissions in Acute Heart Failure: A Randomized Clinical TrialJean-Etienne Ricci, Sylvain Aguilhon, Bob-Valéry Occean, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Archives of Cardiovascular Diseases|April 16, 2016
One-year incidence and clinical impact of bleeding events in patients treated with prasugrel or clopidogrel after ST-segment elevation myocardial infarctionBenoit Lattuca, Pascale Fabbro-Peray, Florence Leclercq, et al.
Heart (British Cardiac Society)|March 15, 2018
Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarctionLamiae Grimaldi-Bensouda, Nicolas Danchin, Jean Dallongeville, et al.
International Journal of Cardiology|April 4, 2015
Impact of prolonged dual antiplatelet therapy after acute myocardial infarction on 5-year mortality in the FAST-MI 2005 registryFrancois Schiele, Etienne Puymirat, Laurent Bonello, et al.
International Journal of Clinical Practice|May 28, 2020
Collaboration between cardiologist and clinical pharmacist on prescription quality: What is the potential clinical impact for cardiology patients?Yohan Audurier, Nicolas Chapet, Pierre Renaudin, et al.
Archives of Cardiovascular Diseases|February 7, 2026
Tafamidis treatment in transthyretin cardiac amyloidosis: A retrospective cohort analysis of outcomes and associated factorsJohanna Krief, Sylvain Aguilhon, Quentin Delbaere, et al.
Archives of Cardiovascular Diseases|June 30, 2023
Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI programOrianne Weizman, Victoria Tea, Eloi Marijon, et al.
Clinical Chemistry and Laboratory Medicine|November 11, 2014
Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarctionKamila Solecki, Anne Marie Dupuy, Nils Kuster, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 6, 2025
A Streamline Strategy for Indication and Length of Telemetry Monitoring After TAVRAntonin Fournier, Pierre Robert, Benoit Lattuca, et al.
International Journal of Cardiology|February 7, 2018
Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA StudyJean-Philippe Collet, Guillaume Cayla, Pierre-Vladimir Ennezat, et al.
Journal of Clinical Medicine|April 12, 2022
Impact of Daily Bedside Echocardiographic Assessment on Readmissions in Acute Heart Failure: A Randomized Clinical TrialJean-Etienne Ricci, Sylvain Aguilhon, Bob-Valéry Occean, et al.
Pageof 12